Altre lingue Vicore Pharma Holding AB

Azioni

VICO

SE0007577895

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:29:39 26/04/2024			Variaz. 5gg	Var. 1 gen.
17,3 ^SEK	+3,72%		+6,00%	+22,00%

04/04	Vicore Pharma Holding AB (Publ) annuncia che Maarten Kraan, membro del Consiglio di Amministrazione, ha rifiutato la rielezione	CI
19/03	Vicore annuncia la designazione di dispositivo innovativo da parte della FDA per AlmeeTM, una terapia digitale per i pazienti con fibrosi polmonare	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Vicore to Present at Upcoming April 2024 Investor Conferences	15/04
Vicore to Present at Upcoming Investor Conferences	15/04
Vicore to Present at Upcoming Investor Conferences	12/04
Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	04/04
Notice of annual general meeting of Vicore Pharma Holding AB (publ)	04/04
Vicore Announces Presentations at the 2024 American Thoracic Society International Conference	28/03
Vicore publishes the Annual Report for 2023	27/03
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Year-end report 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Vicore to Present at Upcoming Investor Conferences	27/02
Vicore Pharma Signs Licensing Deal for Idiopathic Pulmonary Fibrosis Drug Candidate	09/02
Vicore and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize C21 in Japan	09/02
Vicore to Present at Upcoming Investor Conferences	31/01
Alex Therapeutics and Vicore Pharma Announces Positive Results of the COMPANION Study	04/01
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety	04/01
Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis	04/01
Vicore Pharma Holding AB Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates	02/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Vicore Pharma Holding AB

Azioni

VICO

SE0007577895

Altre lingue

Filtri